LBA-001Olaparib as maintenance treatment following first-line platinum-based chemotherapy in patients with a germline BRCA mutation and metastatic pancreatic cancer: phase III POLO trial. (2nd July 2019) - Golan, T; Hammel, P; Reni, M; Van Cutsem, E; Macarulla, T; Hall, M; Park, J; Hochhauser, D; Arnold, D; Oh, D; Reinacher-Schick, A; Tortora, G; et al.